CYTOKINE PROFILE OF LABORATORY INBRED AND TRANSGENIC MICE IN THE EVALUATION OF THE IMMUNOLOGICAL STATUS AND SEARCH FOR NEW PHARMACOLOGICAL REGULATORS
https://doi.org/10.33647/2074-5982-15-2-54-62
Abstract
This article presents the results of studies aimed at investigating the cytokine profile of laboratory mice, including novel data on the cytokine status of transgenic mice NAT1hom and NAT2hom. The investigation of cytokines in the blood serum of laboratory animals was carried out using multiplex xMAP-analysis on magnetic particles. For mice of inbred lines C57BL/6 and Balb/c, data is presented with respect
to changes in the quantitative content of cytokines in the blood plasma after a single injection of the Polymuramyl and Tacrolimus drugs. Effects of the Tacrolimus immunosuppressant and the Polymuramyl
immunomodulator on the mouse cytokine profile were estimated.
A particular attention was paid to the dynamics of the concentration of the tumour necrosis factor (TNF-α) as one of the most important criteria of the biological action of immunomodulators. The production of TNF-α in experimental immunosuppression was determined. The immunomodulating properties of Polymuramyl were confirmed under the conditions of acute inflammation by simulating influenza in mice. It is established that transgenic humanized mice of NAT1hom and NAT2hom lines can be successfully used in immunological studies and search for new pharmacological regulatory molecules metabolized with the participation of body acetylation systems. The obtained data are compared with the effect of inginate — an effective inhibitor of N-acetyltransferase (NAT2) — on the cytokine status. This drug is characterized by a pronounced immunomodulating effect on the production of IFN-gamma and TNF-alpha.
About the Authors
M. S. DulyaRussian Federation
143442, Russian Federation, Moscow region, Krasnogorsk district, Settlement Svetlye Gory, building 1
V. N. Karkischenko
Russian Federation
Dr. Sci. (Med.), Prof.,
143442, Russian Federation, Moscow region, Krasnogorsk district, Settlement Svetlye Gory, building 1
D. V. Khvostov
Russian Federation
143442, Russian Federation, Moscow region, Krasnogorsk district, Settlement Svetlye Gory, building 1
R. A. Ageldinov
Russian Federation
143442, Russian Federation, Moscow region, Krasnogorsk district, Settlement Svetlye Gory, building 1
N. N. Karkischenko
Russian Federation
Dr. Sci. (Med.), Prof., Corresponding Member of the Russian Academy of Sciences, Academician of the Russian Academy of Rocket and Artillery Sciences
143442, Russian Federation, Moscow region, Krasnogorsk district, Settlement Svetlye Gory, building 1
References
1. Beutler B. Inferences, questions and possibilities in Toll-like receptor signaling. Nature. 2004;430:257–263.
2. Karkischenko V.N., Dulya M.S., Khvostov D.V., Ageldinov R.A. K farmakodinamike proizvodnykh fluorena — tilorona i inginata — na osnove ingibirovaniya N-atsetiltransferaz i produktsii tsitokinov [To the pharmacodynamics of fluorene — thylorone and ininate derivatives — based on inhibition of N-acetyltransferases and cytokine production]. Biomedicine. 2017;(4):34–45. (In Russian).
3. Karkischenko V.N., Ryabykh V.P., Karkischenko N.N., Dulya M.S., Ezerskiy V.A., Koloskova E.M., Lazarev V.N., Maksimenko S.V., Petrova N.V., Stolyarova V.N., Trubitsyna T.P. Molekulyarno-geneticheskiye aspekty tekhnologii polucheniya transgennykh myshey s integrirovannymi genami N-atsetiltransferazy (NAT1 i NAT2) cheloveka [Molecular and genetic aspects of technology for producing transgenic mice with integrated N-acetyltransferase genes (NAT1 and NAT2) in humans]. Biomedicine. 2016;(1):4–18. (In Russian).
4. Karkischenko N.N., Ryabykh V.P., Koloskova E.M., Karkischenko V.N. Sozdanie gumanizirovannykh myshey dlya farmakotoksikologicheskikh issledovaniy (uspekhi, neudachi i perspektivy) [Creation of humanized mice for pharmacotoxicological studies (successes, failures and prospects)]. Biomedicine. 2014;(3):4–22. (In Russian).
5. Petrova N.V., Slobodenyuk V.V. Molekulyarno-epigeneticheskiye issledovaniya transgennykh myshey s integrirovannymi genami NAT1 i NAT2 cheloveka v farmakologii [Molecular and epigenetic studies of transgenic mice with integrated human NAT1 and NAT2 genes in pharmacology]. Eksperimental’naya i klinicheskaya farmakologiya. Pril. Mat-ly k 6-j Mezhd. konf. «Biologicheskiye osnovy individual’noy chuvstvitel’nosti k psikhotropnym sredstvam» [Experimental and clinical pharmacology. Application. Materials for the 6th International Conference “Biological Basis of Individual Sensitivity to Psychotropic Drugs”]. 2015;78:49. (In Russian).
6. Ryabykh V.P., Koloskova E.M., Ezerskiy V.A., Trubitsyna T.P., Maksimenko S.V. O perspektivakh polucheniya transgennykh myshey-biomodeley dlya farmakologicheskikh i toksikologicheskikh issledovaniy [On the prospects for obtaining transgenic mice-biomodels for pharmacological and toxicological studies]. Problemy biologii produktivnykh zhivotnykh [Problems of the biology of productive animals]. 2015;2:5–22. (In Russian).
7. Khaitov R.M., Pashchenkov M.V., Pinegin B.V. Rol’ pattern-raspoznayushchikh retseptorov vo vrozhdennom i adaptivnom immunitete [The role of pattern-recognizing receptors in innate and adaptive immunity]. Immunology. 2009;30:66–76. (In Russian).
8. Banchereau J., Briere F., Caux C., et al. Immunobiology of dendritic cells. Annu. Rev. Immunol. 2000;18:767–811.
9. Bernasconi N.L., Onai N., Lanzavecchia A. A role for Toll-like receptors in acquired immunity: upregulation of TLR9 by BCR triggering in naive B cells and constitutive expression in memory B cells. Blood. 2003;101:4500–04.
10. Beutler B. Inferences, questions and possibilities in Toll-like receptor signaling. Nature. 2004;430:257–263.
Review
For citations:
Dulya M.S., Karkischenko V.N., Khvostov D.V., Ageldinov R.A., Karkischenko N.N. CYTOKINE PROFILE OF LABORATORY INBRED AND TRANSGENIC MICE IN THE EVALUATION OF THE IMMUNOLOGICAL STATUS AND SEARCH FOR NEW PHARMACOLOGICAL REGULATORS. Journal Biomed. 2019;(2):54-62. (In Russ.) https://doi.org/10.33647/2074-5982-15-2-54-62